Placebo response in aggressive children with conduct disorder

Area of Science:

• Child and Adolescent Psychiatry
• Behavioral Psychology
• Neurodevelopmental Disorders

Background:

• Conduct disorder (CD) in children can manifest with significant aggressiveness and explosiveness.
• Limited research exists on placebo response in aggressive pediatric populations with CD.
• Differentiating placebo responders from nonresponders is crucial for understanding treatment efficacy.

Purpose of the Study:

• To identify factors distinguishing placebo responders from nonresponders in children with aggressive conduct disorder.
• To explore the influence of psychosocial environment, demographics, and baseline symptoms on placebo response.

Main Methods:

• A sample of 25 children (ages 6.25-11.95) with aggressive CD received placebo as part of a lithium trial.
• Responders and nonresponders were compared on psychosocial environment scores, age, IQ, and psychiatric ratings.
• Psychosocial environment was assessed using a detrimental psychosocial environmental score.

Main Results:

• Children who responded to placebo had significantly higher detrimental psychosocial environmental scores.
• Factors such as coming from violent homes and having criminally charged parents were associated with better placebo response.
• Demographic variables did not differentiate responders from nonresponders, but mild hyperactivity correlated with poorer placebo response.

Conclusions:

• The psychosocial environment plays a significant role in placebo response for aggressive children with conduct disorder.
• Children from more adverse environments may exhibit greater placebo effects in clinical trials.
• Hyperactivity may indicate a need for targeted pharmacological interventions beyond placebo effects.